Highlights
1 patent
About
Regenerative Wound Care Technology
RedDress is the developer of ActiGraft, an FDA-cleared regenerative wound care solution based on the companys proprietary patented technology for reproducing the bodys natural ability to heal wounds. ActiGraft enables healthcare providers to produce, in real-time, in vitro blood clots from a patients whole blood. Once applied, the blood clots serve as a protective covering, biologic scaffold, and wound microenvironment to help promote the bodys natural wound-healing processes.
Identity
| Name | RedDress |
|---|---|
| Slug | reddress |
| Type / kind | startup |
| Crunchbase ID | reddress |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NGQo8EKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Pardes Hanna-Karkur |
| HQ address | Shkedim Street 11, Pardes Hanna-Karkur, Israel |
Web & social
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business models
B2B2CB2BB2C
Tags
pain-reliefhealthcare-providersdiabeteschronic-painmedical-devicesregenerative-medicinemedical-technologies
Funding
| Total raised | $42.5M |
|---|---|
| Current stage | Series D |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}